Literature DB >> 9303415

Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.

C Doit1, J Barre, R Cohen, S Bonacorsi, A Bourrillon, E H Bingen.   

Abstract

Cerebrospinal fluid (CSF) was taken from 19 children with bacterial meningitis treated with cefotaxime (300 mg/kg of body weight/day) and vancomycin (60 mg/kg/day). Median levels of drugs in CSF were smaller than expected, as follows: 4.4 microg/ml for cefotaxime, 3.2 microg/ml for desacetylcefotaxime, and 1.7 microg/ml for vancomycin. The median CSF bactericidal titer against an intermediately cefotaxime-resistant pneumococcus was 1:4. Our data suggest at least an additive interaction between the drugs used in this study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303415      PMCID: PMC164066          DOI: 10.1128/AAC.41.9.2050

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children.

Authors:  M H Lebel; G H McCracken
Journal:  Pediatrics       Date:  1989-02       Impact factor: 7.124

2.  Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Bacterial counts in cerebrospinal fluid of children with meningitis.

Authors:  E Bingen; N Lambert-Zechovsky; P Mariani-Kurkdjian; C Doit; Y Aujard; F Fournerie; H Mathieu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

4.  Spiral plate method for bacterial determination.

Authors:  J E Gilchrist; J E Campbell; C B Donnelly; J T Peeler; J M Delaney
Journal:  Appl Microbiol       Date:  1973-02

5.  Determination of vancomycin in serum and tissues by column liquid chromatography using solid-phase extraction.

Authors:  J Bauchet; E Pussard; J J Garaud
Journal:  J Chromatogr       Date:  1987-03-06

6.  Micromethod for the determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography.

Authors:  F M Demotes-Mainard; G A Vinçon; C H Jarry; H C Albin
Journal:  J Chromatogr       Date:  1984-12-12

7.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

8.  Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.

Authors:  J M Trang; R F Jacobs; G L Kearns; A L Brown; T G Wells; F L Underwood; R B Kluza
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

9.  Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.

Authors:  G H McCracken; Y Sakata
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

10.  Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.

Authors:  B I Asmar; M C Thirumoorthi; J A Buckley; D M Kobos; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  10 in total

1.  Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.

Authors:  F Fitoussi; C Doit; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  D Rodoni; F Hänni; C M Gerber; M Cottagnoud; K Neftel; M G Täuber; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 3.  Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.

Authors:  M A Pfaller; D J Sheehan; J H Rex
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 4.  Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.

Authors:  I Lutsar; I R Friedland
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

5.  Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.

Authors:  N Desbiolles; L Piroth; C Lequeu; C Neuwirth; H Portier; P Chavanet
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Antimicrobial agents from selected medicinal plants in Libya.

Authors:  Hasan M H Muhaisen; Miftah Mailoud Ab-Mous; Fadel A Ddeeb; Aboclaid Ali Rtemi; Omer M Taba; Mehtab Parveen
Journal:  Chin J Integr Med       Date:  2015-04-25       Impact factor: 1.978

7.  Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.

Authors:  E Bingen; C Levy; E Varon; F de La Rocque; M Boucherat; P d'Athis; Y Aujard; R Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-30       Impact factor: 3.267

Review 8.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

9.  In vitro antibacterial and time-kill assessment of crude methanolic stem bark extract of Acacia mearnsii de wild against bacteria in shigellosis.

Authors:  Olufunmiso Olusola Olajuyigbe; Anthony Jide Afolayan
Journal:  Molecules       Date:  2012-02-21       Impact factor: 4.411

10.  Biochemical profile and in vitro biological activities of extracts from seven folk medicinal plants growing wild in southern Tunisia.

Authors:  Hajer Tlili; Najjaa Hanen; Abdelkerim Ben Arfa; Mohamed Neffati; Abdelbasset Boubakri; Daniela Buonocore; Maurizia Dossena; Manuela Verri; Enrico Doria
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.